Pharmaceutical
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India
· Glenmark is the first company in the world to launch Remogliflozin (100 mg) + Vildagliptin (50 mg) Fixed Dose Combination...
Read more
DrOnApp Health partners with Mankind pharma to create awareness about telemedicine
The app is a virtual clinic for patients booking an appointment through m-site link or the ptient appAvailable for both...
Read more
